These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10068984)

  • 1. [Ceftriaxone-induced cholelithiasis].
    Maccherini M; Borlini G; Branchi M; Barbonetti C; Moretti P; Bonora G
    Pediatr Med Chir; 1998; 20(5):341-3. PubMed ID: 10068984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Transient biliary lithiasis associated with the use of ceftriaxone].
    Alvarez-Coca González J; Cebrero García M; Vecilla Rivelles MC; Alonso Cristobo M; Torrijos Roman C
    An Esp Pediatr; 2000 Oct; 53(4):366-8. PubMed ID: 11083990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pseudolithiasis caused by ceftriaxone in children: a case report].
    Benedetti M; Zanchetta S; Bagnani A; Praderio R; Perbellini S; Melo C
    Pediatr Med Chir; 1995; 17(4):369-71. PubMed ID: 7491336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biliary pseudolithiasis in childhood: a case report.
    Herek O; Sarioğlu A; Koçer N; Tiryaki A; Akkemik B
    Eur J Pediatr Surg; 1999 Oct; 9(5):337-9. PubMed ID: 10584197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftriaxone-induced symptomatic pseudolithiasis mimicking ICP elevation.
    Evliyaoglu C; Kizartici T; Bademci G; Unal B; Keskil S
    Zentralbl Neurochir; 2005 May; 66(2):92-4. PubMed ID: 15846537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftriaxone-associated biliary pseudolithiasis in children.
    Herek O; Pakdemirli E; Koçer N
    Eur Radiol; 2001; 11(5):902. PubMed ID: 11372630
    [No Abstract]   [Full Text] [Related]  

  • 7. [Symptomatic pseudolithiasis caused by Rocephalin].
    Tuckuviene R; Myrtue GS
    Ugeskr Laeger; 2000 Aug; 162(32):4271-2. PubMed ID: 10962947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftriaxone-associated biliary sludge and pseudocholelithiasis during childhood: a prospective study.
    Bor O; Dinleyici EC; Kebapci M; Aydogdu SD
    Pediatr Int; 2004 Jun; 46(3):322-4. PubMed ID: 15151550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ceftriaxone-induced cholelithiasis--a harmless side-effect?].
    Riccabona M; Kerbl R; Schwinger W; Spork D; Millner M; Grubbauer HM
    Klin Padiatr; 1993; 205(6):421-3. PubMed ID: 8309205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of ceftriaxone-associated gallbladder pseudolithiasis.
    Papadopoulou F; Efremidis S; Karyda S; Badouraki M; Karatza E; Panteliadis C; Malaka K
    Acta Paediatr; 1999 Dec; 88(12):1352-5. PubMed ID: 10626521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sonographic demonstration of pseudo-cholelithiasis after ceftriaxone].
    Barzilai M
    Harefuah; 1994 Sep; 127(5-6):163-5, 215. PubMed ID: 7995584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors leading to ceftriaxone-associated biliary pseudolithiasis in children.
    Kong MS; Chen CY
    Changgeng Yi Xue Za Zhi; 1996 Mar; 19(1):50-4. PubMed ID: 8935375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early biliary pseudolithiasis during ceftriaxone therapy for acute pyelonephritis in children: a prospective study in 34 children.
    Bonnet JP; Abid L; Dabhar A; Lévy A; Soulier Y; Blangy S
    Eur J Pediatr Surg; 2000 Dec; 10(6):368-71. PubMed ID: 11215777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute cholecystitis and pancreatitis in a patient with biliary sludge associated with the use of ceftriaxone: a rare but potentially severe complication.
    Famularo G; Polchi S; De Simone C
    Ann Ital Med Int; 1999; 14(3):202-4. PubMed ID: 10566187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transitory biliary pseudolithiasis appearing quickly after ceftriaxone treatment].
    Chevrel J; Barbier R; Mondeteguy J
    Arch Pediatr; 1999 Mar; 6(3):336. PubMed ID: 10191906
    [No Abstract]   [Full Text] [Related]  

  • 16. Biliary precipitation during ceftriaxone therapy: frequency and risk factors.
    Soysal A; Eraşov K; Akpinar I; Bakir M
    Turk J Pediatr; 2007; 49(4):404-7. PubMed ID: 18246742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible symptomatic biliary obstruction associated with ceftriaxone pseudolithiasis.
    Zinberg J; Chernaik R; Coman E; Rosenblatt R; Brandt LJ
    Am J Gastroenterol; 1991 Sep; 86(9):1251-4. PubMed ID: 1882806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disappearing "gallstones": biliary pseudolithiasis complicating ceftriaxone therapy.
    Kirejczyk WM; Crowe HM; Mackay IM; Quintiliani R; Cronin EB
    AJR Am J Roentgenol; 1992 Aug; 159(2):329-30. PubMed ID: 1632349
    [No Abstract]   [Full Text] [Related]  

  • 19. Biliary colic and sonographic evidence of pseudocholelithiasos 36 h after treatment with ceftriaxone.
    Rozmanic V; Banac S; Ivosevic D; Cace N
    J Paediatr Child Health; 2006 Oct; 42(10):658-9. PubMed ID: 16972978
    [No Abstract]   [Full Text] [Related]  

  • 20. Iatrogenic gallstones: a ceftriaxone complication.
    Kearney DK; O'Donnell D
    Australas Radiol; 1998 Aug; 42(3):236-7. PubMed ID: 9727252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.